A MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting [ChIP-seq]
Ontology highlight
ABSTRACT: A MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting [ChIP-seq]
PROVIDER: PRJNA1007635 | ENA |
REPOSITORIES: ENA
ACCESS DATA